These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3930062)

  • 1. Resistance of the diabetic rat nerve to ischemic inactivation.
    Jaramillo J; Simard-Duquesne N; Dvornik D
    Can J Physiol Pharmacol; 1985 Jul; 63(7):773-7. PubMed ID: 3930062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs.
    Engerman RL; Kern TS; Larson ME
    Diabetologia; 1994 Feb; 37(2):141-4. PubMed ID: 8163047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.
    Price SA; Agthong S; Middlemas AB; Tomlinson DR
    Diabetes; 2004 Jul; 53(7):1851-6. PubMed ID: 15220210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
    Yue DK; Hanwell MA; Satchell PM; Turtle JR
    Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
    Greene DA; Lattimer SA
    Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ
    FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
    J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
    Price DE; Airey CM; Alani SM; Wales JK
    Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The susceptibility of rat diabetic nerve to ischemia: increased or decreased?
    Nukada H
    J Neurol Sci; 1993 Nov; 119(2):162-8. PubMed ID: 8277330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal transport and nerve conduction velocity in animal models of diabetic neuropathy.
    Tomlinson DR; Mayer JH
    Diabet Med; 1985 May; 2(3):210-2. PubMed ID: 2952422
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
    Malone JI; Lowitt S; Corsico N; Orfalian Z
    Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats.
    Sato D; Kusunoki M; Shinzawa G; Feng Z; Nishina A; Nakamura T
    Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE; Larsen AB; Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mixed bovine brain gangliosides on hypoxic conduction block in control and streptozotocin-diabetic rats.
    Calcutt NA; Carrington AL; Ettlinger CB; Tomlinson DR
    J Neurol Sci; 1992 May; 109(1):96-101. PubMed ID: 1387680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model.
    Akita M; Mizuno K; Matsubara A; Nakano K; Kurono M
    Acta Med Okayama; 1993 Oct; 47(5):299-304. PubMed ID: 8273453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of insulin and sorbinil on myoinositol uptake in peripheral nerve from normal and diabetic rats and a neuroblastoma cell line (N1E-115).
    Dunlop ME; Hill MA; Larkins RG
    Diabetes Res; 1988 Jun; 8(2):51-7. PubMed ID: 3147829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress.
    Song Z; Fu DT; Chan YS; Leung S; Chung SS; Chung SK
    Mol Cell Neurosci; 2003 Aug; 23(4):638-47. PubMed ID: 12932443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.